[go: up one dir, main page]

About Otsuka

Business Collaborators

Central Nervous System

H. Lundbeck A/S (Denmark)
H. Lundbeck A/S
  • Joint development and commercialization of ABILIFY Maintena and REXULTI / RXULTI
  • Joint development and commercialization of Selincro in Japan
Teva Pharmaceutical Industries, Ltd. (Israel)
Teva Pharmaceutical Industries, Ltd.
  • Development and commercialization of AJOVY in Japan
UCB S.A. (Belgium), UCB Japan
UCB S.A.
  • Development and commercialization of NEUPRO Patch in Japan
Sumitomo Pharma Co., Ltd. (Japan)
Sumitomo Pharma Co., Ltd.
  • Joint development and commercialization of ulotaront (SEP-363856), SEP-4199, SEP-378614 and SEP-380135 worldwide
Click Therapeutics, Inc. (U.S.)
Click Therapeutics, Inc.
  • Collaboration on development of digital therapeutic application
Perception Neuroscience, Inc. (U.S.)
Perception Neuroscience, Inc.
  • Development and commercialization of R-ketamine in Japan
Jolly Good Inc. (Japan)
Jolly Good Inc.
  • Joint development and commercialization of the social skills training platform using virtual reality in Japan

Oncology

Takeda Pharmaceutical Company Limited (Japan)
Takeda Pharmaceutical Company Limited
  • Joint development and commercialization of Iclusig in ten Asian countries and regions including Japan
Pierre Fabre (France)
Pierre Fabre
  • Business related to Busulfex in European and South American countries

Cardiovascular and Renal

Novartis Pharma K.K.
(Japanese subsidiary of parent company in Switzerland)
Novartis Pharma K.K.
  • Co-promotion of Entresto in Japan
Esperion Therapeutics, Inc. (U.S.)
Esperion Therapeutics, Inc.
  • Development and commercialization of bempedoic acid in Japan
Aurinia Pharmaceuticals, Inc. (Canada & U.S.)
Aurinia Pharmaceuticals, Inc.
  • Development and commercialization of voclosporin in Japan and Europe

Gastroenterology

Takeda Pharmaceutical Company Limited (Japan)
Takeda Pharmaceutical Company Limited
  • Co-promotion of Takecab and Cabpirin in Japan

Ophthalmology

Senju Pharmaceutical Co., Ltd. (Japan)
Senju Pharmaceutical Co., Ltd.
  • Co-promotion of Mikeluna combination ophthalmic solution, Mikelan ophthalmic solution, Mikelan LA ophthalmic solution, AIBETA combination ophthalmic solution and AILAMIDE combination ophthalmic suspension in Japan

Diagnostics

Eiken Chemical Co., Ltd. (Japan)
Eiken Chemical Co., Ltd.
  • Co-marketing of RAPIRUN and Uropaper
  • Joint research and development of diagnostics
Denka Co., Ltd. (Japan)
Denka Co., Ltd.
  • License for Quick Navi series
Illumina, Inc. (U.S.)
Illumina, Inc.
  • Development and commercialization of IVD test kit for patients in Japan with blood cancer
Ai-BrainScience Inc. (Japan)
Ai-BrainScience Inc.
  • Sales collaboration on the cognitive function testing application that uses Eye Tracking technology